These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19702497)

  • 21. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
    Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
    Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study.
    Mohammadi MR; Yadegari N; Hassanzadeh E; Farokhnia M; Yekehtaz H; Mirshafiee O; Akhondzadeh S
    Clin Neuropharmacol; 2013; 36(6):179-84. PubMed ID: 24201232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal Epidemiological Study of Autism Subgroups Using Autism Treatment Evaluation Checklist (ATEC) Score.
    Mahapatra S; Khokhlovich E; Martinez S; Kannel B; Edelson SM; Vyshedskiy A
    J Autism Dev Disord; 2020 May; 50(5):1497-1508. PubMed ID: 30062397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Folic Acid Supplementation in Autistic Children Participating in Structured Teaching: An Open-Label Trial.
    Sun C; Zou M; Zhao D; Xia W; Wu L
    Nutrients; 2016 Jun; 8(6):. PubMed ID: 27338456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroinflammation in Autism and Supplementation Based on Omega-3 Polyunsaturated Fatty Acids: A Narrative Review.
    Veselinović A; Petrović S; Žikić V; Subotić M; Jakovljević V; Jeremić N; Vučić V
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autism spectrum disorders according to DSM-IV-TR and comparison with DSM-5 draft criteria: an epidemiological study.
    Mattila ML; Kielinen M; Linna SL; Jussila K; Ebeling H; Bloigu R; Joseph RM; Moilanen I
    J Am Acad Child Adolesc Psychiatry; 2011 Jun; 50(6):583-592.e11. PubMed ID: 21621142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms.
    Sheppard KW; Boone KM; Gracious B; Klebanoff MA; Rogers LK; Rausch J; Bartlett C; Coury DL; Keim SA
    J Autism Dev Disord; 2017 Nov; 47(11):3358-3369. PubMed ID: 28748334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot study of D-cycloserine in subjects with autistic disorder.
    Posey DJ; Kem DL; Swiezy NB; Sweeten TL; Wiegand RE; McDougle CJ
    Am J Psychiatry; 2004 Nov; 161(11):2115-7. PubMed ID: 15514414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complementary and Alternative Medicine in Autism: The Question of Omega-3.
    Posar A; Visconti P
    Pediatr Ann; 2016 Mar; 45(3):e103-7. PubMed ID: 27031309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Famotidine treatment of children with autistic spectrum disorders: pilot research using single subject research design.
    Linday LA; Tsiouris JA; Cohen IL; Shindledecker R; DeCresce R
    J Neural Transm (Vienna); 2001; 108(5):593-611. PubMed ID: 11459079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders.
    Richardson AJ
    Int Rev Psychiatry; 2006 Apr; 18(2):155-72. PubMed ID: 16777670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 fatty acids in bipolar disorder: clinical and research considerations.
    Marangell LB; Suppes T; Ketter TA; Dennehy EB; Zboyan H; Kertz B; Nierenberg A; Calabrese J; Wisniewski SR; Sachs G
    Prostaglandins Leukot Essent Fatty Acids; 2006; 75(4-5):315-21. PubMed ID: 16928441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
    Research Units on Pediatric Psychopharmacology Autism Network
    Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intention-based therapy for autism spectrum disorder: promising results of a wait-list control study in children.
    Weiner RH; Greene RL
    Explore (NY); 2014; 10(1):13-23. PubMed ID: 24439092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial.
    Wozniak J; Biederman J; Mick E; Waxmonsky J; Hantsoo L; Best C; Cluette-Brown JE; Laposata M
    Eur Neuropsychopharmacol; 2007; 17(6-7):440-7. PubMed ID: 17258897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.
    Troost PW; Lahuis BE; Steenhuis MP; Ketelaars CE; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1137-44. PubMed ID: 16239862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention deficit/hyperactivity disorder in children and adolescents with autism spectrum disorder: symptom or syndrome?
    Sinzig J; Walter D; Doepfner M
    J Atten Disord; 2009 Sep; 13(2):117-26. PubMed ID: 19380514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.